Report of a Track Seeding of Thyroid Papillary Carcinoma During Robot- Assisted Transaxillary ThyroidectomyEmilien Chabrillac*, Slimane Zerdoud, Pierre Graff-Cailleaud, Sébastien Fontaine and Jérôme Sarini
Surgery Department, University Institute of Cancer of Toulouse, Institute of Claudius Regaud, Toulouse, France
- *Corresponding Author:
- Emilien Chabrillac
4 allée des violettes, 31150 Gagnac sur Garonne, France
E-mail: [email protected]
Received date: June 21, 2017; Accepted date: July 17, 2017; Published date: July 21, 2017
Citation: Chabrillac E, Zerdoud S, Cailleaud PG, Fontaine S, Sarini J (2017) Report of a Track Seeding of Thyroid Papillary Carcinoma During Robot-Assisted Transaxillary Thyroidectomy. Thyroid Disorders Ther 6:218. doi:10.4172/2167-7948.1000218
Copyright: © 2017 Chabrillac E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: The Robotic Thyroidectomy (RT) is a minimally invasive surgical technique initially developed in Asia, for cultural reasons. The principles of its use are still undergoing development. Showing to all appearances satisfying outcomes, the long-time safety and medico-economic benefit of the procedure have not been established yet. The use of this technique in thyroid carcinology remains rare, and provides specific risks, not encountered with the Open Thyroidectomy (OT).
Patient Findings: We report the case of a patient who underwent a two-stages RT for a pT3 follicular carcinoma causing dissemination along the surgical track, in spite of the radioactive iodine treatment.
Summary: This case reminds us the limits of the RT in the oncologic field and the lack of perspective, with the recent discovery of the risk of dissemination along the surgical track. Our synthetic review of the literature comparing RT to OT shows the advantages and limitations of the RT.
Conclusions: The development of the RT should pursue its way, but the use of this procedure in thyroid carcinology must remain reasonable. Further data is necessary to assess the long-term oncologic safety, regarding even the uncommon risks, as the track seeding. To this day, OT remains the gold standard for the complex thyroid pathologies.